Evidence map›Paper›PMID 40507903›Full record

ArticleInternational journal of molecular sciences2025

Doping of Hollow Urchin-like MnO

Enze Qian, Ahmed Eltawila, Yunqing Kang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Enze QianDepartment of Ocean & Mechanical Engineering, Florida Atlantic University, Boca Raton, FL 33431, USA.
Ahmed EltawilaDepartment of Ocean & Mechanical Engineering, Florida Atlantic University, Boca Raton, FL 33431, USA.
Yunqing KangDepartment of Ocean & Mechanical Engineering, Florida Atlantic University, Boca Raton, FL 33431, USA.ORCID 0000-0002-9721-1837

Funding

Develop manganese-containing porous scaffolds with vasculature-like channels for potential applications in craniofacial bone regenerationR15DE032189 · NIDCR · FLORIDA ATLANTIC UNIVERSITY · PI KANG, YUNQING · 2022 to 2022
$444k
Autotherapy of craniofacial bone defects using immunomodulatory and cell-recruiting bioceramic scaffoldsR03DE028406 · NIDCR · FLORIDA ATLANTIC UNIVERSITY · PI KANG, YUNQING · 2019 to 2020
$292k
National Science Foundation 2223702NIDCR NIH HHS R03 DE028406NIDCR NIH HHS R15 DE032189NIH HHS 1R15DE032189-01NIH HHS R03DE028406
6 · The paper itself

Abstract

Effective osteogenesis for bone regeneration is still considerably challenging for a porous β-tricalcium phosphate (β-TCP) scaffold to achieve. To overcome this challenge, hollow manganese dioxide (H-MnO

Indexed as

Calcium PhosphatesCell DifferentiationManganese CompoundsMesenchymal Stem CellsNanoparticlesOsteogenesisOxidesTissue ScaffoldsCell ProliferationCells, CulturedCell SurvivalHumansPorositybeta-tricalcium phosphateCalcium PhosphatesManganese Compoundsmanganese dioxideOxidesbiocompatibilityhBMSChollow MnO2 nanoparticlesosteogenesisβ-TCP scaffold

Identifiers

PMID40507903
PMCPMC12154069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.